Search results for: 'disease of insect'

This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...

The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...

This research service was carried out on three countries in East Africa; Kenya, Tanzania and Uganda. The research service focuses on analysing the market opportunity for testing and monitoring of five key diseases in this region; HIV, malaria, TB, HPV and diabetes. A brief healthcare overview of each country is provided in the research. Additionall...

Healthcare at home is emerging as one of the fastest-growing fields in modern medicine, driven by the rising demand for outpatient services, home-based monitoring, treatment, and rehabilitation. Increasing patient loads in clinics and hospitals have spurred federal initiatives that encourage the adoption of innovative solutions for decentralized ca...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments in female contraception technique, small molecule drugs, cell and gene therapies, cancer diagnosis and treatment and nanobody technologies. The research also encompasses emerging innovations across infectious and immu...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent advancements across small molecules and biologics for cancer treatment. The research also covers innovations for the diagnosis and management of neurological disorders, apart from provide insights for the management of immunological...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprises insights across new developments for antibody-drug conjugates, T-cell engagers, cell and gene therapies, precision immunology and cancer care.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life science...